Victory Capital Management Inc Nex Immune, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$4.11 - $15.13 $49,196 - $181,106	-11,970 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$10.32 - $16.9 $2,105 - $3,447	204 Added 1.73%	11,970 $181,000
Q2 2021 Aug 03, 2021	BUY	$14.98 - $23.89 $10,800 - $17,224	721 Added 6.53%	11,766 $192,000
Q1 2021 May 04, 2021	BUY	$17.95 - $25.91 $198,257 - $286,175	11,045 New	11,045 $211,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $5.07M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.